Form 4 for QDEL QuidelOrtho Corp
Accepted 2023-05-16 00:00:00 ET · period of report 2023-05-14 · accession 0001209191-23-029931 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-16 | 2023-05-14 | QDEL | POLAN MARY LAKE PH D | Dir | A - Grant | $0.00 | +1,137 | 4,437 | +34% | $0 |
| DM | 2023-05-16 | 2023-05-14 | QDEL | POLAN MARY LAKE PH D | Dir | M - OptEx | $0.00 | -1,137 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-14 | A | A | 875 | $0.00 | 4,175 | D | — | — | (F1) Reflects release of restricted stock units that were previously reported on a Form 4. |
| 2 | Common | Common Stock | 2023-05-14 | A | A | 262 | $0.00 | 4,437 | D | — | — | (F1) Reflects release of restricted stock units that were previously reported on a Form 4. |
| 3 | Derivative | Restricted Stock Units (Premium) | 2023-05-14 | M | D | 262 | $0.00 | 0 | D | — · — to — | 262 Common Stock | (F2) Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. (F3) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. |
| 4 | Derivative | Restricted Stock Units (Converted) | 2023-05-14 | M | D | 875 | $0.00 | 0 | D | — · — to — | 875 Common Stock | (F2) Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. (F3) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. |